Lista de obras - Jadwiga Wardas - Dominio Público Uruguay

(S)-4C3HPG, a mixed group I mGlu receptor antagonist and a group II agonist, administered intrastriatally, counteracts parkinsonian-like muscle rigidity in rats

artículo científico publicado en 2001

1,2,3,4-Tetrahydroisoquinoline protects terminals of dopaminergic neurons in the striatum against the malonate-induced neurotoxicity

artículo científico publicado en 2005

A slowly developing dysfunction of dopaminergic nigrostriatal neurons induced by long-term paraquat administration in rats: an animal model of preclinical stages of Parkinson's disease?

artículo científico publicado en 2005

Adaptive down-regulation of the serotonin transporter in the 6-hydroxydopamine-induced rat model of preclinical stages of Parkinson's disease and after chronic pramipexole treatment.

artículo científico publicado en 2015

Adenosine A(2a) receptor antagonists: potential therapeutic and neuroprotective effects in Parkinson's disease

artículo científico publicado en 2001

Adenosine A2 receptors stimulate c-fos expression in striatal neurons of 6-hydroxydopamine-lesioned rats

artículo científico publicado en 1995

Adenosine A2A Receptors: Localization and Function

Adenosine A2A receptor agonists increase Fos-like immunoreactivity in mesolimbic areas

artículo científico publicado en 1997

Age-related changes in glutamate receptors: an autoradiographic analysis

artículo científico publicado en 1997

Alterations of BDNF and trkB mRNA expression in the 6-hydroxydopamine-induced model of preclinical stages of Parkinson's disease: an influence of chronic pramipexole in rats.

artículo científico publicado en 2015

An influence of ligands of metabotropic glutamate receptor subtypes on parkinsonian-like symptoms and the striatopallidal pathway in rats

artículo científico publicado en 2006

Apomorphine enhances harmaline-induced tremor in rats.

artículo científico publicado en 2014

Blockade of A2aAdenosine Receptors Positively Modulates Turning Behaviour and c-Fos Expression Induced by D1Agonists in Dopamine-denervated Rats

artículo científico publicado en 1996

Blockade of adenosine A2A receptors inhibits Tremulous Jaw Movements as well as expression of zif-268 and GAD65 mRNAs in brain motor structures

artículo científico publicado en 2022

Chronic haloperidol and clozapine administration increases the number of cortical NMDA receptors in rats.

artículo científico publicado en 1999

Chronic treatments with haloperidol and clozapine alter the level of NMDA-R1 mRNA in the rat brain: an in situ hybridization study

artículo científico publicado en 2002

Contribution of the serotonin 5-HT1A receptor agonism of 8-OH-DPAT and EMD 128130 to the regulation of haloperidol-induced muscle rigidity in rats

artículo científico publicado en 2003

Decline in motor functions in aging is related to the loss of NMDA receptors.

artículo científico publicado en 2001

Degeneration of dopaminergic mesocortical neurons and activation of compensatory processes induced by a long-term paraquat administration in rats: implications for Parkinson's disease.

artículo científico publicado en 2006

Different effects of intranigral and intrastriatal administration of the proteasome inhibitor lactacystin on typical neurochemical and histological markers of Parkinson's disease in rats.

artículo científico publicado en 2011

Does reserpine induce parkinsonian rigidity?

artículo científico publicado en 1995

Dynamic changes in pro- and anti-inflammatory cytokines in microglia after PPAR-γ agonist neuroprotective treatment in the MPTPp mouse model of progressive Parkinson's disease

article

Effect of 1,2,3,4,-tetrahydroisoquinoline administration under conditions of CYP2D inhibition on dopamine metabolism, level of tyrosine hydroxylase protein and the binding of [3H]GBR 12,935 to dopamine transporter in the rat nigrostriatal, dopaminer

artículo científico publicado en 2004

Effects of adenosine receptor antagonists on the in vivo LPS-induced inflammation model of Parkinson's disease

artículo científico publicado en 2013

Evidence for a role of glycine in area tempestas for triggering convulsive seizures

artículo científico publicado en 1990

Evidence for the independent role of GABA synapses of the zona incerta-lateral hypothalamic region in haloperidol-induced catalepsy

artículo científico publicado en 1988

Further evidence for the subsensitivity of striatal AMPA receptors, induced by chronic haloperidol administration: an autoradiographic study.

artículo científico publicado en 1996

GABA mechanisms of ventromedial thalamic nucleus in morphine-induced muscle rigidity

artículo científico publicado en 1986

Impulse control disorders and dopamine dysregulation syndrome associated with dopamine agonist therapy in Parkinson's disease

artículo científico publicado en 2009

Inactivation of neuronal forebrain A receptors protects dopaminergic neurons in a mouse model of Parkinson's disease

artículo científico publicado en 2009

Influence of CGS 21680, a selective adenosine A(2A) agonist, on the phencyclidine-induced sensorimotor gating deficit and motor behaviour in rats

artículo científico publicado en 2003

Influence of acute and chronic 1,2,3,4-tetrahydroisoquinoline administration on the expression of proenkephalin mRNA in the rat striatum.

artículo científico publicado en 2003

Influence of caffeine on 3,4-methylenedioxymethamphetamine-induced dopaminergic neuron degeneration and neuroinflammation is age-dependent.

artículo científico publicado en 2015

Influence of paraquat on dopaminergic transporter in the rat brain

artículo científico publicado en 2005

Inhibition of Excessive Glutamatergic Transmission in the Ventral Thalamic Nuclei by a Selective Adenosine A1 Receptor Agonist, 5'-Chloro-5'-Deoxy-(±)-ENBA Underlies its Tremorolytic Effect in the Harmaline-Induced Model of Essential Tremor

scientific article published on 11 January 2020

Interactions of the tricyclic antidepressant drug amitriptyline with L-DOPA in the striatum and substantia nigra of unilaterally 6-OHDA-lesioned rats. Relevance to motor dysfunction in Parkinson's disease

scientific article published on 02 October 2018

Involvement of adenosine A2A receptors in the induction of c-fos expression by clozapine and haloperidol.

artículo científico publicado en 1999

Involvement of the nucleus accumbens in the myorelaxant effect of baclofen in rats.

artículo científico publicado en 1994

Lateral hypothalamus-zona incerta region as an output station for the catalepsy induced by the blockade of striatal D1 and D2 dopamine receptors

artículo científico publicado en 1990

Lu AF21934, a positive allosteric modulator of mGlu4 receptors, reduces the harmaline-induced hyperactivity but not tremor in rats.

artículo científico publicado en 2014

MPTP-induced dopamine neuron degeneration and glia activation is potentiated in MDMA-pretreated mice

artículo científico publicado en 2013

Neuroprotective and anti-inflammatory effects of the adenosine A(2A) receptor antagonist ST1535 in a MPTP mouse model of Parkinson's disease

artículo científico publicado en 2011

Neuroprotective role of adenosine in the CNS.

artículo científico publicado en 2002

New therapies for the treatment of Parkinson's disease: adenosine A2A receptor antagonists

artículo científico publicado en 2005

Partial lesion of the dopaminergic innervation of the ventral striatum induces "depressive-like" behavior of rats

artículo científico publicado en 2011

Potential antipsychotic action of the selective agonist of adenosine A1 receptors, 5'-Cl-5'-deoxy-ENBA, in amphetamine and MK-801 rat models

artículo científico publicado en 2020

Potential antipsychotic and extrapyramidal effects of (R,S)-3,4-dicarboxyphenylglycine [(R,S)-3,4-DCPG], a mixed AMPA antagonist/mGluR8 agonist

artículo científico publicado en 2004

Potential role of adenosine A2A receptors in the treatment of schizophrenia

artículo científico publicado en 2008

Pramipexole Reduces zif-268 mRNA Expression in Brain Structures involved in the Generation of Harmaline-Induced Tremor

artículo científico publicado en 2020

Pramipexole at a Low Dose Induces Beneficial Effect in the Harmaline-induced Model of Essential Tremor in Rats.

artículo científico publicado en 2015

Pramipexole but not imipramine or fluoxetine reverses the "depressive-like" behaviour in a rat model of preclinical stages of Parkinson's disease.

artículo científico publicado en 2014

Protective effect of 1-methyl-1,2,3,4-tetrahydroisoquinoline against dopaminergic neurodegeneration in the extrapyramidal structures produced by intracerebral injection of rotenone

artículo científico publicado en 2004

Role of adenosine A2A receptors in parkinsonian motor impairment and l-DOPA-induced motor complications

artículo científico publicado en 2007

Role of the metabotropic glutamate receptor subtype 1 in the harmaline-induced tremor in rats.

artículo científico publicado en 2009

Rosiglitazone decreases peroxisome proliferator receptor-γ levels in microglia and inhibits TNF-α production: new evidences on neuroprotection in a progressive Parkinson's disease model.

artículo científico publicado en 2011

SCH 58261, a selective adenosine A2A receptor antagonist, decreases the haloperidol-enhanced proenkephalin mRNA expression in the rat striatum

artículo científico publicado en 2003

SCH 58261, an A(2A) adenosine receptor antagonist, counteracts parkinsonian-like muscle rigidity in rats

artículo científico publicado en 2001

Specific involvement of striatal D1 and D2 dopamine receptors in the neuroleptic catalepsy in rats

scientific article published on 01 July 1995

Striatal and nucleus accumbens D1/D2 dopamine receptors in neuroleptic catalepsy

artículo científico publicado en 1990

Synergistic effect of SCH 58261, an adenosine A2A receptor antagonist, and L-DOPA on the reserpine-induced muscle rigidity in rats

artículo científico publicado en 2003

The Pathophysiology and Treatment of Essential Tremor: The Role of Adenosine and Dopamine Receptors in Animal Models

artículo científico publicado en 2021

The Small GTP-Binding Protein Rhes Influences Nigrostriatal-Dependent Motor Behavior During Aging

artículo científico publicado en 2016

The influence of group III metabotropic glutamate receptor stimulation by (1S,3R,4S)-1-aminocyclo-pentane-1,3,4-tricarboxylic acid on the parkinsonian-like akinesia and striatal proenkephalin and prodynorphin mRNA expression in rats.

artículo científico publicado en 2007

The role of gamma-aminobutyric acid mechanisms of the zona incerta-lateral hypothalamus in the catalepsy and muscle rigidity evoked by morphine

artículo científico publicado en 1987

The role of glutamate receptors in antipsychotic drug action

artículo científico publicado en 2000

The role of metabotropic glutamate receptors in regulation of striatal proenkephalin expression: implications for the therapy of Parkinson's disease.

artículo científico publicado en 2003

The role of striatal adenosine A2A receptors in regulation of the muscle tone in rats.

artículo científico publicado en 1999

The role of striatal metabotropic glutamate receptors in Parkinson's disease.

artículo científico publicado en 2002

The striopallidal pathway is involved in antiparkinsonian-like effects of the blockade of group I metabotropic glutamate receptors in rats.

artículo científico publicado en 2003

Toxic influence of subchronic paraquat administration on dopaminergic neurons in rats.

artículo científico publicado en 2007

Treatment with 1,2,3,4,-tetrahydroisoquinoline affects glutamate release in the striatum but not the binding of [3H]MK-801 to NMDA receptors in the dopaminergic structures of the rat brain

artículo científico publicado en 2009

Tremorolytic effect of 5'-chloro-5'-deoxy-(±)-ENBA, a potent and selective adenosine A1 receptor agonist, evaluated in the harmaline-induced model in rats

artículo científico publicado en 2017

Widespread reduction of dopamine cell bodies and terminals in adult rats exposed to a low dose regimen of MDMA during adolescence

artículo científico publicado en 2017

Zaburzenia zachowania fazy snu REM jako wczesny marker choroby Parkinsona

Zona incerta-lateral hypothalamus as an output structure for impulses involved in neuroleptic drug-induced catalepsy

artículo científico publicado en 1993

Lista de obras de Jadwiga Wardas

(S)-4C3HPG, a mixed group I mGlu receptor antagonist and a group II agonist, administered intrastriatally, counteracts parkinsonian-like muscle rigidity in rats

1,2,3,4-Tetrahydroisoquinoline protects terminals of dopaminergic neurons in the striatum against the malonate-induced neurotoxicity

A slowly developing dysfunction of dopaminergic nigrostriatal neurons induced by long-term paraquat administration in rats: an animal model of preclinical stages of Parkinson's disease?

Adaptive down-regulation of the serotonin transporter in the 6-hydroxydopamine-induced rat model of preclinical stages of Parkinson's disease and after chronic pramipexole treatment.

Adenosine A(2a) receptor antagonists: potential therapeutic and neuroprotective effects in Parkinson's disease

Adenosine A2 receptors stimulate c-fos expression in striatal neurons of 6-hydroxydopamine-lesioned rats

Adenosine A2A Receptors: Localization and Function

Adenosine A2A receptor agonists increase Fos-like immunoreactivity in mesolimbic areas

Age-related changes in glutamate receptors: an autoradiographic analysis

Alterations of BDNF and trkB mRNA expression in the 6-hydroxydopamine-induced model of preclinical stages of Parkinson's disease: an influence of chronic pramipexole in rats.

An influence of ligands of metabotropic glutamate receptor subtypes on parkinsonian-like symptoms and the striatopallidal pathway in rats

Apomorphine enhances harmaline-induced tremor in rats.

Blockade of A2aAdenosine Receptors Positively Modulates Turning Behaviour and c-Fos Expression Induced by D1Agonists in Dopamine-denervated Rats

Blockade of adenosine A2A receptors inhibits Tremulous Jaw Movements as well as expression of zif-268 and GAD65 mRNAs in brain motor structures

Chronic haloperidol and clozapine administration increases the number of cortical NMDA receptors in rats.

Chronic treatments with haloperidol and clozapine alter the level of NMDA-R1 mRNA in the rat brain: an in situ hybridization study

Contribution of the serotonin 5-HT1A receptor agonism of 8-OH-DPAT and EMD 128130 to the regulation of haloperidol-induced muscle rigidity in rats

Decline in motor functions in aging is related to the loss of NMDA receptors.

Degeneration of dopaminergic mesocortical neurons and activation of compensatory processes induced by a long-term paraquat administration in rats: implications for Parkinson's disease.

Different effects of intranigral and intrastriatal administration of the proteasome inhibitor lactacystin on typical neurochemical and histological markers of Parkinson's disease in rats.

Does reserpine induce parkinsonian rigidity?

Dynamic changes in pro- and anti-inflammatory cytokines in microglia after PPAR-γ agonist neuroprotective treatment in the MPTPp mouse model of progressive Parkinson's disease

Effect of 1,2,3,4,-tetrahydroisoquinoline administration under conditions of CYP2D inhibition on dopamine metabolism, level of tyrosine hydroxylase protein and the binding of [3H]GBR 12,935 to dopamine transporter in the rat nigrostriatal, dopaminer

Effects of adenosine receptor antagonists on the in vivo LPS-induced inflammation model of Parkinson's disease

Evidence for a role of glycine in area tempestas for triggering convulsive seizures

Evidence for the independent role of GABA synapses of the zona incerta-lateral hypothalamic region in haloperidol-induced catalepsy

Further evidence for the subsensitivity of striatal AMPA receptors, induced by chronic haloperidol administration: an autoradiographic study.

GABA mechanisms of ventromedial thalamic nucleus in morphine-induced muscle rigidity

Impulse control disorders and dopamine dysregulation syndrome associated with dopamine agonist therapy in Parkinson's disease

Inactivation of neuronal forebrain A receptors protects dopaminergic neurons in a mouse model of Parkinson's disease

Influence of CGS 21680, a selective adenosine A(2A) agonist, on the phencyclidine-induced sensorimotor gating deficit and motor behaviour in rats

Influence of acute and chronic 1,2,3,4-tetrahydroisoquinoline administration on the expression of proenkephalin mRNA in the rat striatum.

Influence of caffeine on 3,4-methylenedioxymethamphetamine-induced dopaminergic neuron degeneration and neuroinflammation is age-dependent.

Influence of paraquat on dopaminergic transporter in the rat brain

Inhibition of Excessive Glutamatergic Transmission in the Ventral Thalamic Nuclei by a Selective Adenosine A1 Receptor Agonist, 5'-Chloro-5'-Deoxy-(±)-ENBA Underlies its Tremorolytic Effect in the Harmaline-Induced Model of Essential Tremor

Interactions of the tricyclic antidepressant drug amitriptyline with L-DOPA in the striatum and substantia nigra of unilaterally 6-OHDA-lesioned rats. Relevance to motor dysfunction in Parkinson's disease

Involvement of adenosine A2A receptors in the induction of c-fos expression by clozapine and haloperidol.

Involvement of the nucleus accumbens in the myorelaxant effect of baclofen in rats.

Lateral hypothalamus-zona incerta region as an output station for the catalepsy induced by the blockade of striatal D1 and D2 dopamine receptors

Lu AF21934, a positive allosteric modulator of mGlu4 receptors, reduces the harmaline-induced hyperactivity but not tremor in rats.

MPTP-induced dopamine neuron degeneration and glia activation is potentiated in MDMA-pretreated mice

Neuroprotective and anti-inflammatory effects of the adenosine A(2A) receptor antagonist ST1535 in a MPTP mouse model of Parkinson's disease

Neuroprotective role of adenosine in the CNS.

New therapies for the treatment of Parkinson's disease: adenosine A2A receptor antagonists

Partial lesion of the dopaminergic innervation of the ventral striatum induces "depressive-like" behavior of rats

Potential antipsychotic action of the selective agonist of adenosine A1 receptors, 5'-Cl-5'-deoxy-ENBA, in amphetamine and MK-801 rat models

Potential antipsychotic and extrapyramidal effects of (R,S)-3,4-dicarboxyphenylglycine [(R,S)-3,4-DCPG], a mixed AMPA antagonist/mGluR8 agonist

Potential role of adenosine A2A receptors in the treatment of schizophrenia

Pramipexole Reduces zif-268 mRNA Expression in Brain Structures involved in the Generation of Harmaline-Induced Tremor

Pramipexole at a Low Dose Induces Beneficial Effect in the Harmaline-induced Model of Essential Tremor in Rats.

Pramipexole but not imipramine or fluoxetine reverses the "depressive-like" behaviour in a rat model of preclinical stages of Parkinson's disease.

Protective effect of 1-methyl-1,2,3,4-tetrahydroisoquinoline against dopaminergic neurodegeneration in the extrapyramidal structures produced by intracerebral injection of rotenone

Role of adenosine A2A receptors in parkinsonian motor impairment and l-DOPA-induced motor complications

Role of the metabotropic glutamate receptor subtype 1 in the harmaline-induced tremor in rats.

Rosiglitazone decreases peroxisome proliferator receptor-γ levels in microglia and inhibits TNF-α production: new evidences on neuroprotection in a progressive Parkinson's disease model.

SCH 58261, a selective adenosine A2A receptor antagonist, decreases the haloperidol-enhanced proenkephalin mRNA expression in the rat striatum

SCH 58261, an A(2A) adenosine receptor antagonist, counteracts parkinsonian-like muscle rigidity in rats

Specific involvement of striatal D1 and D2 dopamine receptors in the neuroleptic catalepsy in rats

Striatal and nucleus accumbens D1/D2 dopamine receptors in neuroleptic catalepsy

Synergistic effect of SCH 58261, an adenosine A2A receptor antagonist, and L-DOPA on the reserpine-induced muscle rigidity in rats

The Pathophysiology and Treatment of Essential Tremor: The Role of Adenosine and Dopamine Receptors in Animal Models

The Small GTP-Binding Protein Rhes Influences Nigrostriatal-Dependent Motor Behavior During Aging

The influence of group III metabotropic glutamate receptor stimulation by (1S,3R,4S)-1-aminocyclo-pentane-1,3,4-tricarboxylic acid on the parkinsonian-like akinesia and striatal proenkephalin and prodynorphin mRNA expression in rats.

The role of gamma-aminobutyric acid mechanisms of the zona incerta-lateral hypothalamus in the catalepsy and muscle rigidity evoked by morphine

The role of glutamate receptors in antipsychotic drug action

The role of metabotropic glutamate receptors in regulation of striatal proenkephalin expression: implications for the therapy of Parkinson's disease.

The role of striatal adenosine A2A receptors in regulation of the muscle tone in rats.

The role of striatal metabotropic glutamate receptors in Parkinson's disease.

The striopallidal pathway is involved in antiparkinsonian-like effects of the blockade of group I metabotropic glutamate receptors in rats.

Toxic influence of subchronic paraquat administration on dopaminergic neurons in rats.

Treatment with 1,2,3,4,-tetrahydroisoquinoline affects glutamate release in the striatum but not the binding of [3H]MK-801 to NMDA receptors in the dopaminergic structures of the rat brain

Tremorolytic effect of 5'-chloro-5'-deoxy-(±)-ENBA, a potent and selective adenosine A1 receptor agonist, evaluated in the harmaline-induced model in rats

Widespread reduction of dopamine cell bodies and terminals in adult rats exposed to a low dose regimen of MDMA during adolescence

Zaburzenia zachowania fazy snu REM jako wczesny marker choroby Parkinsona

Zona incerta-lateral hypothalamus as an output structure for impulses involved in neuroleptic drug-induced catalepsy